Literature DB >> 23438758

Immunotherapy: Oncolytic vaccinia virus shows promise in liver cancer.

Vanessa Marchesi.   

Abstract

Entities:  

Year:  2013        PMID: 23438758     DOI: 10.1038/nrclinonc.2013.31

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Authors:  Jeong Heo; Tony Reid; Leyo Ruo; Caroline J Breitbach; Steven Rose; Mark Bloomston; Mong Cho; Ho Yeong Lim; Hyun Cheol Chung; Chang Won Kim; James Burke; Riccardo Lencioni; Theresa Hickman; Anne Moon; Yeon Sook Lee; Mi Kyeong Kim; Manijeh Daneshmand; Kara Dubois; Lara Longpre; Minhtran Ngo; Cliona Rooney; John C Bell; Byung-Geon Rhee; Richard Patt; Tae-Ho Hwang; David H Kirn
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

2.  Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.

Authors:  Caroline J Breitbach; Rozanne Arulanandam; Naomi De Silva; Steve H Thorne; Richard Patt; Manijeh Daneshmand; Anne Moon; Carolina Ilkow; James Burke; Tae-Ho Hwang; Jeong Heo; Mong Cho; Hannah Chen; Fernando A Angarita; Christina Addison; J Andrea McCart; John C Bell; David H Kirn
Journal:  Cancer Res       Date:  2013-02-07       Impact factor: 12.701

  2 in total
  1 in total

1.  Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma.

Authors:  So Young Yoo; Su-Nam Jeong; Dae Hwan Kang; Jeong Heo
Journal:  Oncotarget       Date:  2017-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.